[Introduction of the human recombinant angiogenin at the early stages of postnatal development inhibits the growth of mice].
We studied the influence of recombinant DNA containing the cloned angiogenin gene, plasmid DNA without angiogenin gene, and purified recombinant angiogenin injected to Tg8 mice at the age of two days on the body mass of 28- and 40-day old mice. The body mass of mice that were injected with the cloned angiogenin gene or purified angiogenin was less than in the control mice. The body mice of Tg8 mice injected with recombinant DNA containing the cloned angiogenin gene did not increase from day 2 to day 40, while in the mice with purified recombinant angiogenin and control mice it increased by 24 and 57%, respectively. These data suggest that the elevated level of angiogenin at the early developmental stages inhibits the increase of body mass. The effect we described as related, in al likelihood, to the known inhibitory effect of angiogenin on protein synthesis.
Mertvetsov
N P
NP
Institute of Cytology and Genetics, Russian Academy of Sciences, pr. Lavrent'eva 10, Novosibirsk, 630090 Russia.
Voĭtenko
N N
NN
Dudarev
A N
AN
Ivanova
E A
EA
Khaĭdarova
N V
NV
Popova
N K
NK
Tarantul
V Z
VZ
D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight / Q000187:drug effects / Q000235:genetics; D006128:Growth / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008995:Monoamine Oxidase / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics / Q000494:pharmacology; D012259:Ribonuclease, Pancreatic / Q000235:genetics* / Q000494:pharmacology
D011994:Recombinant Proteins; D008995:Monoamine Oxidase; C046366:angiogenin; D012259:Ribonuclease, Pancreatic